et al., Prevent Senior Institute, São Paulo, Brazil (Preprint)
Empirical treatment with hydroxych loroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine
636 patients. HC
Q+AZ reduced hospitalization 79% when used within 7 days (65% overall). Non-randomized.
hospitalization, ↓64.0%, p=0.02
Please send us corrections, updates, or comments.